1 |
Brazikumab |
Brazikumab |
[1] D10912 D10912 💬 |
IL23A [1] IL23A 💬 |
C-type lectin receptor signaling pathway [9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
096 [2] 96, 97 💬 |
2 |
Brazikumab high dose |
Brazikumab |
[1] D10912 D10912 💬 |
IL23A [1] IL23A 💬 |
C-type lectin receptor signaling pathway [9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
096 [1] 96 💬 |
3 |
Brazikumab iv infusion |
Brazikumab |
[1] D10912 D10912 💬 |
IL23A [1] IL23A 💬 |
C-type lectin receptor signaling pathway [9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
096 [1] 96 💬 |
4 |
Brazikumab low dose |
Brazikumab |
[1] D10912 D10912 💬 |
IL23A [1] IL23A 💬 |
C-type lectin receptor signaling pathway [9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
096 [1] 96 💬 |
5 |
Brazikumab sc injection |
Brazikumab |
[1] D10912 D10912 💬 |
IL23A [1] IL23A 💬 |
C-type lectin receptor signaling pathway [9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
096 [1] 96 💬 |